Literature DB >> 27464983

Brain invasion in otherwise benign meningiomas does not predict tumor recurrence.

Peter Baumgarten1, Florian Gessler1, Jens Schittenhelm2,3, Marco Skardelly3,4, Dominique S Tews5, Christian Senft1, Maika Dunst5, Lioba Imoehl1, Karl H Plate5,6,7, Marlies Wagner8, Joachim P Steinbach6,7,9, Volker Seifert1, Michel Mittelbronn5,6,7, Patrick N Harter10,11,12.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27464983     DOI： 10.1007/s00401-016-1598-1

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN： 0001-6322            Impact factor:   17.088


× No keyword cloud information.
  20 in total

Review 1.  Prognostic significance of brain invasion in meningiomas: systematic review and meta-analysis.

Authors:  Satoshi Nakasu; Yoko Nakasu
Journal:  Brain Tumor Pathol       Date:  2021-01-06       Impact factor: 3.298

2.  WHO grade I meningiomas: classification-tree for prognostic factors of survival.

Authors:  Jean-Michel Lemée; Holger Joswig; Michele Da Broi; Marco Vincenzo Corniola; David Scheie; Karl Schaller; Eirik Helseth; Torstein R Meling
Journal:  Neurosurg Rev       Date:  2019-06-10       Impact factor: 3.042

Review 3.  Diagnostic challenges in meningioma.

Authors:  Martha Nowosielski; Norbert Galldiks; Sarah Iglseder; Philipp Kickingereder; Andreas von Deimling; Martin Bendszus; Wolfgang Wick; Felix Sahm
Journal:  Neuro Oncol       Date:  2017-11-29       Impact factor: 12.300

Review 4.  [Tumors of the inner ear and adjacent structures].

Authors:  J Schittenhelm
Journal:  Pathologe       Date:  2017-11       Impact factor: 1.011

Review 5.  Brain invasion in meningiomas-clinical considerations and impact of neuropathological evaluation: a systematic review.

Authors:  Benjamin Brokinkel; Katharina Hess; Christian Mawrin
Journal:  Neuro Oncol       Date:  2017-10-01       Impact factor: 12.300

6.  Histopathological predictors of progression-free survival in atypical meningioma: a single-center retrospective cohort and meta-analysis.

Authors:  Min-Sung Kim; Se-Woong Chun; Yun-Sik Dho; Youngbeom Seo; Joo Ho Lee; Jae Kyung Won; Jin Wook Kim; Chul-Kee Park; Sung-Hye Park; Yong Hwy Kim
Journal:  Brain Tumor Pathol       Date:  2022-01-15       Impact factor: 3.298

7.  Clinical and pathological impact of an optimal assessment of brain invasion for grade 2 meningioma diagnosis: lessons from a series of 291 cases.

Authors:  Thiébaud Picart; Chloé Dumot; Jacques Guyotat; Vladislav Pavlov; Nathalie Streichenberger; Alexandre Vasiljevic; Tanguy Fenouil; Anne Durand; Emmanuel Jouanneau; François Ducray; Timothée Jacquesson; Moncef Berhouma; David Meyronet
Journal:  Neurosurg Rev       Date:  2022-04-29       Impact factor: 2.800

8.  Microscopic brain invasion in meningiomas previously classified as WHO grade I is not associated with patient outcome.

Authors:  Annamaria Biczok; Christine Jungk; Rupert Egensperger; Andreas von Deimling; Bogdana Suchorska; Joerg C Tonn; Christel Herold-Mende; Christian Schichor
Journal:  J Neurooncol       Date:  2019-11-11       Impact factor: 4.130

9.  Commentary: The Ki-67 Proliferation Index as a Marker of Time to Recurrence in Intracranial Meningioma.

Authors:  Antonio Dono; Ankush Chandra; Leomar Y Ballester; Yoshua Esquenazi
Journal:  Neurosurgery       Date:  2021-06-15       Impact factor: 4.654

10.  EANO guideline on the diagnosis and management of meningiomas.

Authors:  Roland Goldbrunner; Pantelis Stavrinou; Michael D Jenkinson; Felix Sahm; Christian Mawrin; Damien C Weber; Matthias Preusser; Giuseppe Minniti; Morten Lund-Johansen; Florence Lefranc; Emanuel Houdart; Kita Sallabanda; Emilie Le Rhun; David Nieuwenhuizen; Ghazaleh Tabatabai; Riccardo Soffietti; Michael Weller
Journal:  Neuro Oncol       Date:  2021-11-02       Impact factor: 13.029
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.